Prices as of 2026/10/30 close
Company comparison · Pharmaceutical & Medical Distribution
Medipal is the bigger company, with revenue of ¥3.8T — 2.5x Toho Holdings's ¥1.6T.
Medipal earns more on each yen of sales, with an operating margin of 1.4% — 0.3 points above Toho Holdings (1.1%).
Revenue growth in the latest results: Medipal +4.0%, Toho Holdings +2.3%. For next year, Medipal guides for the fastest operating profit growth (+3.4%).
Medipal pays more on average — ¥8.14M against ¥6.79M at Toho Holdings.
Over the past year the shares moved Medipal +37.9%, Toho Holdings −18.3%.
Head-to-head wins14 metrics
One win per metric for the company with the best value. Metrics with no better or worse (P/E, average age, employees) are excluded.
ScaleInvestors
Medipal aheadMedipal 3 : Toho Holdings 0
Revenue: Medipal ¥3.8T / Toho Holdings ¥1.6T
ProfitabilityInvestors
Medipal aheadMedipal 2 : Toho Holdings 1
Operating margin: Medipal 1.4% / Toho Holdings 1.1%
GrowthInvestors
Medipal aheadMedipal 4 : Toho Holdings 0
Revenue growth (YoY): Medipal +4.0% / Toho Holdings +2.3%
Stock & balance sheetInvestors
Medipal aheadMedipal 2 : Toho Holdings 0
Share price, 1 year: Medipal +37.9% / Toho Holdings −18.3%
Pay & workforceJob seekers
Medipal aheadMedipal 2 : Toho Holdings 0
Average salary: Medipal ¥8.14M / Toho Holdings ¥6.79M
| Metric | Medipal | Toho Holdings | Gap |
|---|---|---|---|
| Revenue | ◎¥3.8T | ¥1.6T | 2.5x |
| Operating profit | ◎¥53.2B | ¥16.6B | 3.2x |
| Net income | ◎¥42.5B | ¥17.3B | 2.5x |
| Metric | Medipal | Toho Holdings | Gap |
|---|---|---|---|
| Operating margin | ◎1.4% | 1.1% | 0.3pt |
| Net margin | 1.1% | ◎1.1% | 0.0pt |
| ROE | — | 6.6% | |
| Revenue per employee | ◎¥20.6B | ¥7.8B | 2.6x |
| Metric | Medipal | Toho Holdings | Gap |
|---|---|---|---|
| Revenue growth (YoY) | ◎+4.0% | +2.3% | 1.7pt |
| Operating profit growth (YoY) | ◎−4.4% | −12.3% | 7.9pt |
| Revenue CAGRlast 5 years | +3.5% | — | |
| Guidance: revenue growthnext FY plan | ◎+3.3% | +3.1% | 0.3pt |
| Guidance: op. profit growthnext FY plan | ◎+3.4% | −10.8% | 14.3pt |
| Metric | Medipal | Toho Holdings | Gap |
|---|---|---|---|
| Share price, 1 year | ◎+37.9% | −18.3% | 56.2pt |
| Share price, 3 months | ◎+14.6% | −4.2% | 18.8pt |
| P/E (trailing)lower = cheaper | — | 14.8x | |
| Equity ratio | — | 36.7% | |
| Share price (close) | ¥3,441 | ¥4,004 |
◎ marks the best value for each metric. Revenue and profit are from the latest full-year earnings release; share prices are closing-price references; P/E = latest close ÷ trailing EPS. For banks and some other financials, revenue means ordinary income.
| Metric | Medipal | Toho Holdings | Gap |
|---|---|---|---|
| Average salary | ◎¥8.14M | ¥6.79M | ¥1.35M |
| Starting salary (monthly) | — | ¥215,000 | |
| Average tenure | ◎19.8 yrs | 18.9 yrs | 0.9 |
| Average age | 48.6 | 48.3 | 0.3 |
| Employees | 185 | 199 | 1.1x |
Average salary is for the reporting (parent) company and is affected by average age and job mix. Holding companies with few employees are left out of the salary comparison.
Close (Oct 30, 2026)
¥3,441+37.9% (1Y)
Medipal +37.9% over 1Y. Compared: Toho Holdings -18.3%.
Reference chart of daily closing prices, not real-time quotes (split-adjusted; weekly closes before the last year). Each line shows the % change from the start of the period. Updated Oct 30, 2026.
Medipal3 segments
Toho Holdings4 segments
AAverage annual salary from the securities filings: Medipal ¥8.14M, Toho Holdings ¥6.79M. Medipal pays the most. Averages also depend on staff age and job mix, so check the average age too (Medipal 48.6, Toho Holdings 48.3).
ARevenue in the latest results: Medipal ¥3.8T, Toho Holdings ¥1.6T. Medipal is the bigger company, with revenue of ¥3.8T — 2.5x Toho Holdings's ¥1.6T.
AOperating margins: Medipal 1.4%, Toho Holdings 1.1%. Medipal turns the highest share of sales into operating profit.
AShare price change over the past year (closing prices, for reference): Medipal +37.9%, Toho Holdings −18.3%. Medipal has risen the most.
Comparing 2 companies (up to 4)
Sources: earnings releases (kessan tanshin), annual securities reports and other public information. Share prices are closing-price references, not real-time. Our data may contain errors; investment decisions are your own responsibility.
